Free Trial 中
Wind ESG Rating

Access to ESG rating for China A-Shares and Hong Kong listed companies.

成都先导

688222.SH
Wind Industry: 医疗保健 > 医药生物 > 生命科学工具和服务Ⅲ > 生命科学工具和服务Ⅳ

公司致力于打造国际领先的创新型生物医药企业，总部位于中国成都，在英国剑桥、美国休斯顿设有子公司。公司聚焦小分子及核酸新药的发现与优化，着力打造了国际领先的DNA编码化合物库技术(DEL)平台，并拓展了基于分子片段和三维结构信息的药物设计技术(FBDD/SBDD)、基于寡核苷酸的药物研发技术(OBT)和靶向蛋白降解技术(TPD)的核心技术平台；同时，公司正在建设DEL+AI+自动化DMTA(设计-合成-测试-分析)分子优化能力平台，以期加速临床前候选药物发现及优化过程。通过新药研发服务、不同阶段在研项目转让以及远期的药物上市等多元化的商业模式，公司与全球数百家制药公司、生物技术公司、化学公司、基金会以及科研机构建立了合作。目前，公司有多个内部新药项目处于临床及临床前不同阶段。

ESG Score Industry Ranking:
8 / 36 (生命科学工具和服务Ⅲ)

ESG Rating Distribution(生命科学工具和服务Ⅲ)

Trend of Rating

2022-08-01: BB; 2023-08-01: BB; 2024-08-01: BB; 2025-08-07: A; 2026-07-17: AA BB2022.08 BB2023.08 BB2024.08 A2025.08 AA2026.07

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：8.11Updated on 2026-10-29
08.1110
Management & Practices Score：5.12Updated on 2026-10-02
05.127
Controversies Score：2.99Updated on 2026-10-29
02.993

ESG Score Comparison

Environmental Social Governance 成都先导生命科学工具和服务Ⅲ Average
IndicatorCompany ScoreIndustry AverageWeight
Environmental6.023.7915.43%
Social7.595.1558.35%
Governance7.466.3326.22%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

  • 500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
  • 1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB
More Details

Peer Comparison(36 companies in the industry) ?

RankingCodeSecurity NameESG RatingESG ScoreControversies ScoreManagement & Practices ScoreEnvironmentalSocialGovernance
1688114.SH华大智造AA8.822.985.856.928.778.25
2300725.SZ药石科技AA8.523.005.528.877.338.55
3002821.SZ凯莱英A8.442.985.476.417.968.30
4301230.SZ泓博医药AA8.332.975.366.798.137.13
5688131.SH皓元医药AA8.312.995.316.307.847.79
6688238.SH和元生物AA8.212.785.434.788.617.58
7688202.SH美迪西AA8.192.975.225.247.937.68
8688222.SH成都先导AA8.112.995.126.027.597.46
9300759.SZ康龙化成AA8.052.935.127.677.436.83
9603259.SH药明康德AA8.052.995.077.746.568.46